Filing Details
- Accession Number:
- 0001219036-21-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-27 19:40:18
- Reporting Period:
- 2021-09-23
- Accepted Time:
- 2021-09-27 19:40:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219036 | S Jerry Lanchbury | 320 Wakara Way Salt Lake City UT 84108 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-09-23 | 200 | $35.06 | 288,515 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-25 | 9,747 | $33.31 | 278,768 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-09-26 | 3,633 | $33.31 | 275,135 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021.
Billionaire Hedge Funds
